Search results
Displaying 21 - 30 of 44 results
-
Opioid implementation package
This package outlines the next steps and what the options are to make a significant difference in opioid-induced adverse drug events.
-
Update on Ora® product supply shortage (September 2023)
Due to a manufacturing issue, Ora® products are likely to be in limited supply for the coming months before resupply in early November 2023.
-
Margaret's story: Understanding the side effects of medicines
In this video, Margaret Pye shares how she experienced constipation following use of morphine.
-
Helen McKernan discusses mother's hospital treatment
Helen McKernan talks about her mother’s death, following a hospital medication error. Helen's mother was given the wrong medication for four days because of a chart mix up and inadequate checking.
-
Safety Signal: Changes to the labelling of Bicillin LA®
Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3
-
Safe Medication Management newsletters - 2010
Newsletters from the SMM programme for the year 2010
-
Applying for specify brand advice status
Use this application form to apply for a new or changed specify brand advice listing.
-
Some medicines for epilepsy, mental health, and pain can harm your unborn baby
A booklet and a flyer from ACC with information for people who could get pregnant, and their families and whānau, understand the risks and benefits of taking anti-seizure medicines for epilepsy, mental health and pain.
-
Display of combination product medicines in electronic systems
Guidelines for the display of combination product medicines in electronic systems.
-
Consumer flyer: Ask your pharmacist for advice about your medicines
Consumer flyer: help with your medicines is available – ask your pharmacist for advice.